ISSN: 0312-8008

Journal Home

Australian Prescriber Q2 Unclaimed

Therapeutic Guidelines Ltd Australia

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Australian Prescriber is a journal indexed in SJR in Pharmacology (medical) with an H index of 40. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system The scope of the journal is focused on medicine, therapeutics, drugs, pharmacy. It has an SJR impact factor of 0,675 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,675.

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Pharmacology (medical) (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,675

SJR Impact factor

40

H Index

27

Total Docs (Last Year)

205

Total Docs (3 years)

415

Total Refs

260

Total Cites (3 years)

103

Citable Docs (3 years)

1.16

Cites/Doc (2 years)

15.37

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Drug Safety - Case Reports Q2
AIDS Research and Therapy Q2
Pharmacopsychiatry Q2
Experimental and Clinical Psychopharmacology Q2
Expert Review of Anticancer Therapy Q2

Compare this journals

Aims and Scope

Medicine Therapeutics Drugs Pharmacy

Best articles by citations

Experimental and Clinical Pharmacology: Clinical implications of renin inhibitors

Experimental and Clinical Pharmacology: Dopamine- mechanisms of action

Experimental and Clinical Pharmacology: Renin inhibitors - mechanisms of action

Heparins for venous thromboembolism prophylaxis - safety issues

Severe hyponatraemia due to mirtazapine

Are new drugs as good as they claim to be?

The value of PubMed and HighWire Press for the busy general practitioner

Drugs in breastfeeding

Dental patients taking warfarin

Prescribing in liver disease

Is Australia free from direct-to-customer advertising?

Choosing a combined oral contraceptive pill

SHOW MORE ARTICLES

Warfarin pharmacogenetics

Flying and thromboembolism

Abnormal laboratory results: Anti-Xa assays

Abnormal laboratory results: Screening for multiple myeloma

Patient support organisation: Finding a patient support group

The management of hepatitis B

Drug treatment of pituitary tumours

Comment: Meldonium and the WADA Prohibited List

BCG vaccine in Australia

Therapeutic Guidelines: Dermatology. Version 3

Therapeutic Guidelines: Endocrinology. Version 4

Prescription pricing demystified